Home JournalsJournal Details
ISSN: 0167-7659 eISSN: 1573-7233 CAS Zone: Medicine (Zone 2) Emerging Zone: Medicine (Zone 1) No

CANCER AND METASTASIS REVIEWS

Abbr. CANCER METAST REV ·UNITED STATES ·Frequency Quarterly ·Avg. articles/yr 41 articles
12.7
Latest IF
1.10%
Self-citation
较难
Submission difficulty
较慢,6 - 12周
Review cycle
About Journal

Cancer and Metastasis Reviews (ISSN 0167-7659) is a prestigious quarterly journal published by Springer in the United States, dedicated to advancing the understanding of cancer biology and metastasis through high-quality, systematic reviews. As a non-open access publication indexed in the Science Citation Index (SCI), the journal maintains a consistently high impact factor and is typically ranked in the second or third quartile of the Chinese Academy of Sciences journal classification for medicine and oncology, reflecting its strong standing in the academic community. The scope of the journal encompasses a broad spectrum of interdisciplinary research, including fundamental mechanisms of metastasis, therapeutic strategies, and clinical translation, thereby bridging the gap between basic science and clinical application. By prioritizing comprehensive summaries of frontier developments over original experimental studies, Cancer and Metastasis Reviews serves as a critical resource for senior researchers and clinicians seeking authoritative insights into the field. Although its subscription-based model may limit immediate dissemination compared to open-access alternatives, the journal’s rigorous editorial standards and focus on synthesizing complex data ensure it remains a highly competitive and respected venue for experts aiming to contribute to the broader discourse on cancer metastasis.

Recent Articles
2025-03-12
Epigenetic drugs in cancer therapy
Suraweera A, O’Byrne K, Richard D · Vol 44(1)
2025-02-26
2025-02-18
Neuronal mimicry in tumors: lessons from neuroscience to tackle cancer
Bloomer H, Dame H, Parker S et al · Vol 44(1)
2025-02-11
2025-02-06
Advancements in gene therapies targeting mutant KRAS in cancers
Wang Y, Bui T, Yang X et al · Vol 44(1)
2025-01-17
2025-01-17
2025-01-08
2025-01-06
Journal Info
ISSN
0167-7659
Abbr.
CANCER METAST REV
Region
UNITED STATES
Frequency
Quarterly
CAS Zone
Medicine (Zone 2) · Non-Top
Emerging Zone
Medicine (Zone 1) · Non-Top
Open Access
No
Research Area
Medicine - Oncology
Coverage
Science Citation Index
Sub-categories
ONCOLOGYZone 2
Emerging Categories
ONCOLOGYZone 2
Submission & Homepage
Submit Homepage
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com